HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael G Ison Selected Research

peramivir

1/2015Peramivir: an intravenous neuraminidase inhibitor.
12/2014Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.
1/2014Intravenous peramivir for treatment of influenza in hospitalized patients.
1/2013Clinical use of approved influenza antivirals: therapy and prophylaxis.
1/2013A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.
12/2011Antivirals and resistance: influenza virus.
12/2011Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration.
3/2011Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael G Ison Research Topics

Disease

38Human Influenza (Influenza)
12/2022 - 08/2002
34Infections
12/2022 - 03/2006
18COVID-19
04/2022 - 11/2020
8Communicable Diseases (Infectious Diseases)
01/2019 - 11/2009
6Virus Diseases (Viral Diseases)
10/2021 - 02/2008
5Bacterial Infections (Bacterial Infection)
01/2021 - 01/2015
3Hepatitis B
01/2021 - 11/2009
3Pneumonia (Pneumonitis)
04/2008 - 12/2005
2Critical Illness (Critically Ill)
04/2022 - 10/2018
2Adenoviridae Infections (Adenovirus Infections)
01/2022 - 04/2008
2Hyperammonemia
01/2022 - 04/2015
2Neoplasms (Cancer)
10/2021 - 01/2021
2Hepatitis C
01/2021 - 01/2011
2Respiratory Insufficiency (Respiratory Failure)
11/2020 - 03/2011
2Hypertension (High Blood Pressure)
10/2020 - 01/2011
2Opportunistic Infections (Opportunistic Infection)
12/2019 - 06/2017
2Tuberculosis (Tuberculoses)
01/2017 - 10/2012
1Paramyxoviridae Infections (Parainfluenza)
01/2022
1Orthostatic Hypotension (Postural Hypotension)
01/2022
1Mucormycosis
06/2021
1Mycoses (Diseases, Fungus)
01/2021
1Acute Lung Injury
11/2020
1Bronchiolitis Obliterans Syndrome
11/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2020
1Lymphoma (Lymphomas)
11/2020
1Nausea
10/2020
1Hypersensitivity (Allergy)
06/2020
1Exanthema (Rash)
06/2019
1Fever (Fevers)
06/2019
1Urinary Tract Infections (Urinary Tract Infection)
06/2019
1Dysbiosis
10/2018
1Inflammation (Inflammations)
10/2018
1Cytomegalovirus Infections (Inclusion Disease)
04/2018
1Clostridium Infections
06/2017
1Chagas Disease (American Trypanosomiasis)
01/2017

Drug/Important Bio-Agent (IBA)

28Antiviral Agents (Antivirals)IBA
12/2022 - 08/2002
14Neuraminidase (Sialidase)IBA
01/2022 - 08/2002
12Oseltamivir (Tamiflu)FDA Link
12/2022 - 03/2006
8peramivirIBA
01/2015 - 03/2011
7VaccinesIBA
01/2022 - 02/2011
6Pharmaceutical PreparationsIBA
01/2022 - 06/2010
5Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 03/2008
5Explosive Agents (Explosives)IBA
01/2021 - 12/2020
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2021
4baloxavirIBA
01/2022 - 10/2020
4Zanamivir (Relenza)FDA Link
10/2021 - 06/2003
4Nucleic AcidsIBA
01/2021 - 11/2009
4RimantadineFDA LinkGeneric
03/2017 - 06/2003
3EndonucleasesIBA
01/2022 - 04/2019
3N-acetyltalosaminuronic acid (NAT)IBA
01/2021 - 11/2009
3Amantadine (Aman)FDA LinkGeneric
03/2017 - 12/2011
2RNA (Ribonucleic Acid)IBA
03/2022 - 12/2015
2Monoclonal AntibodiesIBA
01/2022 - 01/2022
2oplunofuspIBA
01/2022 - 12/2012
2InterferonsIBA
01/2022 - 10/2012
2AntibodiesIBA
10/2021 - 03/2021
2Immunoglobulin G (IgG)IBA
10/2021 - 03/2021
2Carbapenems (Carbapenem Antibiotics)IBA
02/2021 - 01/2015
2Ganciclovir (Cytovene)FDA LinkGeneric
04/2018 - 04/2018
2laninamivirIBA
01/2013 - 12/2011
2AntigensIBA
12/2011 - 02/2005
1pimodivirIBA
12/2022
1Hemoglobins (Hemoglobin)IBA
04/2022
1NucleoproteinsIBA
01/2022
1bamlanivimabIBA
01/2022
1brincidofovirIBA
01/2022
1UreaseIBA
01/2022
1Dichlorodiphenyldichloroethane (DDD)IBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1Neutralizing AntibodiesIBA
01/2021
1favipiravirIBA
01/2021
1Interleukin-2 (IL2)IBA
11/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2020
1ibrutinibIBA
11/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2020
1emt protein-tyrosine kinase (IL2-inducible T-cell kinase)IBA
11/2020
1Transaminases (Aminotransferases)IBA
10/2020
1beta-LactamsIBA
06/2020
1Penicillins (Penicillin)FDA Link
06/2020
1beta Lactam AntibioticsIBA
06/2020
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
01/2020
1methenamine hippurate (Hiprex)FDA LinkGeneric
06/2019
1AcidsIBA
10/2018
1Bile Acids and Salts (Bile Acids)IBA
10/2018
1ValganciclovirFDA Link
04/2018
1FoscarnetFDA LinkGeneric
04/2018
1CreatinineIBA
12/2016

Therapy/Procedure

16Therapeutics
01/2022 - 03/2006
10Transplantation
01/2022 - 11/2009
7Organ Transplantation
01/2022 - 11/2009
6Liver Transplantation
10/2019 - 10/2008
3Kidney Transplantation
06/2021 - 08/2008
3Stem Cell Transplantation
06/2010 - 02/2008
2Length of Stay
08/2022 - 10/2019
2Artificial Respiration (Mechanical Ventilation)
11/2020 - 03/2011
2Chemoprevention
01/2019 - 01/2019
2Drug Therapy (Chemotherapy)
10/2012 - 04/2008
1Cell Transplantation
11/2020
1Secondary Prevention
10/2020
1Heart Transplantation (Grafting, Heart)
06/2019